Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial.
Saved in:
| Title: | Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial. |
|---|---|
| Authors: | de Azambuja, E.1, Zardavas, D.1, Lemort, M.1, Rossari, J.2, Moulin, C.3, Buttice, A.1, D'Hondt, V.1, Lebrun, F.1, Lalami, Y.1, Cardoso, F.4, Sotiriou, C.1, Gil, T.1, Devriendt, D.1, Paesmans, M.1, Piccart-Gebhart, M.1, Awada, A.1 |
| Source: | Annals of Oncology. Dec2013, Vol. 24 Issue 12, p2985-2989. 5p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
